Company Filing History:
1 out of 2,405 
1 out of 1 
1 out of 1,477 
Years Active: 2025
Title: Michael B. Garrigou: Innovator in Cancer Therapeutics
Introduction: Michael B. Garrigou, an accomplished inventor based in Newton, MA, has made significant contributions in the field of cancer research. With a focus on developing innovative compounds, his work targets specific mutations in cancer-related proteins, showcasing the intersection of chemistry and medicine.
Latest Patents: Michael B. Garrigou holds a patent for "Macrocyclic peptides as potent inhibitors of K-RAS G12D mutant." This invention presents a series of compounds that have the potential to inhibit the G12D mutant of the Kirsten rat sarcoma (K-Ras) protein. These compounds and their pharmaceutically acceptable salts are anticipated to serve as therapeutic agents, offering new avenues for cancer treatment. The patent also encompasses pharmaceutical compositions containing these compounds and outlines methods for their use in therapy and prophylaxis against cancer.
Career Highlights: Throughout his career, Michael has been associated with prominent companies in the pharmaceutical sector. Notably, he has worked with Merck Sharp & Dohme Corporation and MSD International GmbH (Singapore Branch). His roles have likely contributed to his expertise in drug development and innovation in the field of pharmaceuticals.
Collaborations: His collaborations with leading pharmaceutical companies have provided him with a platform to advance his research and reach a broader audience. The synergy between his innovative work and the resources of these organizations has enabled significant progress in therapeutic strategies for cancer.
Conclusion: Michael B. Garrigou's patent and career reflect a commitment to fighting cancer through scientific innovation. His work not only advances our understanding of cancer therapies but also highlights the vital role of inventors in transforming scientific discoveries into tangible medical solutions. Through his contributions, Garrigou exemplifies how innovation in the pharmaceutical industry can lead to breakthroughs that improve patient outcomes.